Douglas Chee

687 total citations
14 papers, 142 citations indexed

About

Douglas Chee is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Douglas Chee has authored 14 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Douglas Chee's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Alcohol Consumption and Health Effects (3 papers). Douglas Chee is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Alcohol Consumption and Health Effects (3 papers). Douglas Chee collaborates with scholars based in Singapore, United States and United Kingdom. Douglas Chee's co-authors include Cheng Han Ng, Mark Muthiah, Rebecca Wenling Zeng, Kai En Chan, Caitlyn Tan, Darren Jun Hao Tan, Daniel Q. Huang, Clarissa Elysia Fu, Wen Hui Lim and Jie Ning Yong and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Douglas Chee

13 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Chee Singapore 7 97 63 26 26 21 14 142
Sui‐Weng Wong Malaysia 6 133 1.4× 69 1.1× 43 1.7× 14 0.5× 23 1.1× 6 170
Yajing Zang United Kingdom 2 95 1.0× 37 0.6× 47 1.8× 15 0.6× 35 1.7× 2 134
Zhen Yu Wong United Kingdom 8 108 1.1× 58 0.9× 40 1.5× 8 0.3× 8 0.4× 31 158
Zong-Li Yuan China 8 48 0.5× 41 0.7× 14 0.5× 14 0.5× 37 1.8× 12 136
Unggul Budihusodo Indonesia 6 129 1.3× 81 1.3× 26 1.0× 9 0.3× 24 1.1× 8 146
Hansen Dang Vietnam 3 63 0.6× 42 0.7× 16 0.6× 10 0.4× 17 0.8× 7 85
Tania N. Kamphaus United States 4 73 0.8× 34 0.5× 26 1.0× 7 0.3× 15 0.7× 7 123
Anne Linde Mak Netherlands 8 152 1.6× 82 1.3× 50 1.9× 8 0.3× 57 2.7× 13 210
Ziyan Pan Australia 9 147 1.5× 53 0.8× 63 2.4× 8 0.3× 31 1.5× 24 172
Kensuke Munekage Japan 7 120 1.2× 48 0.8× 63 2.4× 6 0.2× 22 1.0× 12 144

Countries citing papers authored by Douglas Chee

Since Specialization
Citations

This map shows the geographic impact of Douglas Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Chee more than expected).

Fields of papers citing papers by Douglas Chee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Chee. The network helps show where Douglas Chee may publish in the future.

Co-authorship network of co-authors of Douglas Chee

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Chee. A scholar is included among the top collaborators of Douglas Chee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Chee. Douglas Chee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chee, Douglas, et al.. (2025). Global Health Policies for Hepatocellular Carcinoma: A Cross-Sectional Study. Clinical Gastroenterology and Hepatology. 1 indexed citations
2.
Chee, Douglas, Cheng Han Ng, Karn Wijarnpreecha, et al.. (2024). Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH. Transplantation Direct. 10(7). e1642–e1642. 5 indexed citations
3.
Tang, Nicole K. Y., Benjamin Koh, Douglas Chee, et al.. (2024). Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study. HepatoBiliary Surgery and Nutrition. 14(2). 222–232.
4.
Lim, Wen Hui, Phoebe Wen Lin Tay, Cheng Han Ng, et al.. (2024). Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics. 59(6). 730–741. 6 indexed citations
5.
Zeng, Rebecca Wenling, Jie Ning Yong, Darren Jun Hao Tan, et al.. (2023). Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary Pharmacology & Therapeutics. 57(6). 600–609. 52 indexed citations
6.
Lim, Wen Hui, Jie Ning Yong, Cheng Han Ng, et al.. (2023). Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US. Liver Transplantation. 29(11). 1181–1191. 2 indexed citations
7.
Chee, Douglas, Cheng Han Ng, Kai En Chan, et al.. (2023). The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases. Medical Clinics of North America. 107(3). 397–421. 2 indexed citations
8.
Wong, Zhen Yu, Mark Muthiah, Benjamin Koh, et al.. (2023). Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis. Digestive Diseases and Sciences. 69(1). 289–297. 8 indexed citations
9.
Ng, Cheng Han, Ansel Shao Pin Tang, Jieling Xiao, et al.. (2023). Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals. Hepatology Communications. 7(3). e0005–e0005. 23 indexed citations
10.
Li, Wenhao, Cheng Han Ng, Jingxuan Quek, et al.. (2022). The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience. The HKU Scholars Hub (University of Hong Kong). 2(4). 19–19. 5 indexed citations
11.
Gorny, Alexander Wilhelm, Douglas Chee, & Falk Müller‐Riemenschneider. (2022). Active Use and Engagement in an mHealth Initiative Among Young Men With Obesity: Mixed Methods Study. JMIR Formative Research. 6(1). e33798–e33798. 8 indexed citations
12.
Chan, Kai En, Cheng Han Ng, Clarissa Elysia Fu, et al.. (2022). The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals. Clinical Gastroenterology and Hepatology. 21(10). 2560–2569.e15. 19 indexed citations
13.
Tan, Caitlyn, Kai En Chan, Cheng Han Ng, et al.. (2022). DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals. Journal of Clinical Medicine. 11(20). 6205–6205. 1 indexed citations
14.
Nah, Benjamin, Cheng Han Ng, Kai En Chan, et al.. (2022). Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals. International Journal of Environmental Research and Public Health. 19(16). 9935–9935. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026